Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
Open Access
- 1 October 2010
- journal article
- practice guideline
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 126 (4), 800-808
- https://doi.org/10.1542/peds.2010-1534
Abstract
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insufficient to make a recommendation regarding other glucocorticoid doses and preparations. The clinician must use clinical judgment when attempting to balance the potential adverse effects of glucocorticoid treatment with those of bronchopulmonary dysplasia.Keywords
This publication has 57 references indexed in Scilit:
- Impact of Postnatal Corticosteroid Use on Neurodevelopment at 18 to 22 Months' Adjusted Age: Effects of Dose, Timing, and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight InfantsPediatrics, 2009
- Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled TrialsPediatrics, 2009
- Neonate hippocampal volumes: Prematurity, perinatal predictors, and 2‐year outcomeAnnals of Neurology, 2008
- Outcomes of Extremely Low Birth Weight (<1 kg) and Extremely Low Gestational Age (<28 Weeks) Infants With Bronchopulmonary Dysplasia: Effects of Practice Changes in 2000 to 2003Pediatrics, 2008
- Early hypoadrenalism in premature infants at risk for bronchopulmonary dysplasia or deathActa Paediatrica, 2007
- Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infantsThe Journal of Pediatrics, 2005
- Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapyEuropean Journal of Pediatrics, 2005
- A randomized trial of two dexamethasone regimens to reduce side‐effects in infants treated for chronic lung disease of prematurityJournal of Paediatrics and Child Health, 2004
- Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of PrematurityNew England Journal of Medicine, 2004
- Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infantsPediatric Pulmonology, 2003